Clinical Studies Support the Use of Longport's Technology
December 07 2006 - 8:00AM
Business Wire
Longport, Inc. (OTC PK: LPTI), a medical technology specialist in
high-frequency, high-resolution ultrasound imaging, today announced
that two papers have recently been published in peer-reviewed
journals that report on the utilization of Longport�s EPISCAN
system. The first paper, published in the November/December 2006
issue of Advances in Skin & Wound Care, presents the use of
Longport�s EPISCAN for imaging the pathology of early-stage
pressure ulcers and the utility of high-resolution ultrasound in
the early detection of this condition. This paper concludes, �A
better understanding of the pathogenesis of pressure ulcers through
the use of high-resolution ultrasound to detect soft tissue damage
and edema before visible clinical signs could lead to earlier and
more focused pressure ulcer prevention programs, resulting in
reduced pain and suffering for improved patient quality of life and
wound care cost savings.� The full reference to this paper is: Use
of High-Resolution, High-Frequency Diagnostic Ultrasound to
Investigate the Pathogenesis of Pressure Ulcer Development.
Advances in Skin & Wound Care. 19(9):498-505, November/December
2006. The second paper, published in the Tissue Viability
Supplement of the British Journal of Nursing, reports on a case
study using high-resolution ultrasound to assess chronic wounds.
One of the key points of this paper is, �High-frequency ultrasound
could be used to image and quantify changes in the wounds as a
means of non-invasively visualizing wound characteristics which
would otherwise be missed using standard visual assessments alone.�
The full reference to this paper is: Has Packing Sinus Wounds
Become a Ritualistic Practice? British Journal of Nursing - Volume
15, Number 19: 26 October-8 November 2006. Tissue Viability
Supplement, pages S27-30. Further details on both papers can be
viewed at the News section of Longport�s website:
http://www.longportinc.com/about/news.html. �These studies
contribute to the validation of our technology essential for the
documentation of positive clinical outcomes, clinical acceptance
and clinical use,� said Connie Phillips-Jones, RN, MSN Longport�s
Director of Clinical Support. About Longport, Inc. Longport, Inc.
of Glen Mills, Pennsylvania, is a medical technology company that
specializes in high-resolution ultrasound imaging. After several
years and a multimillion dollar investment in the technology,
Longport has secured patents, copyrights and FDA permission to
market. The Company�s technology has been used to engineer a unique
high-resolution ultrasound imaging system. For further information
please contact Longport, Inc. at 1-800-289-6863 or visit our
website at www.longportinc.com. Forward-looking Information and the
Private Securities Litigation Reform Act of 1995 Certain statements
in this press release, including statements concerning product
development milestones and anticipated events, are �forward-looking
statements� within the Private Litigation Reform Act of 1995.
Forward-Looking Statements are based on the opinions and estimates
of management at the time the statements are made and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those anticipated in the forward-looking
statements. The words �believe,� �expect,� �intend,� �anticipate,�
variations of such words, and similar expressions identify
forward-looking statements, but their absence does not mean that
the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict.
Factors that could affect Longport�s actual results include, among
others, uncertainties as to the Company�s ability to manage
potential problems, delays or anticipated expenses, including
problems, delays or expenses involving manufacturing. Readers are
cautioned not to place undue reliance upon these forward-looking
statements that speak only to the date of this release. Reference
is made to Longport�s 2004 annual report on Form 10-K filed with
the Securities and Exchange Commission for a more definitive
description of such factors. Longport, Inc. undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date of
this release or to reflect the occurrence of unanticipated events.
Longport (CE) (USOTC:LPTI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Longport (CE) (USOTC:LPTI)
Historical Stock Chart
From Dec 2023 to Dec 2024